Dr. Wolf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
# 1
Ann Arbor, MI 48109Phone+1 734-936-8051
Education & Training
- National Cancer InstituteFellowship, Tumor Immunology, 1978 - 1980
- SUNY Upstate Medical UniversityResidency, Otolaryngology - Head and Neck Surgery, 1975 - 1978
- MedStar Health/Georgetown-Washington HospitalResidency, Surgery, 1973 - 1975
- District of Columbia General HospitalResidency, Surgery, 1974 - 1974
- University of Michigan Medical SchoolClass of 1973
Certifications & Licensure
- MI State Medical License 1980 - 2023
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Alpha Omega Alpha
- Albert Nelson Marquis Lifetime Achievement Award 2018
- President, American Head and Neck Society 2012
- Join now to see all
Clinical Trials
- S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Start of enrollment: 2005 Dec 01
- A Phase II Trial of Preoperative Soy Isoflavone Supplementation and Molecular Markers in the Prevention of Head and Neck Squamous Carcinoma Start of enrollment: 2010 Feb 01
- IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity Start of enrollment: 2016 Jan 11
Publications & Presentations
PubMed
- 618 citationsGenomic and Functional Approaches to Understanding Cancer AneuploidyAlison M. Taylor, Juliann Shih, Gavin Ha, Galen F. Gao, Xiaoyang Zhang
Cancer Cell. 2018-04-09 - 81 citationsAltered Antigen Expression Predicts Outcome in Squamous Cell Carcinoma of the Head and NeckGregory T. Wolf, Thomas E. Carey, S Schmaltz, Kenneth D. McClatchey, Judy Poore
Journal of the National Cancer Institute. 1990-10-03 - 1362 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M. Wolf, Alexander J. Lazar
Cell. 2018-04-05
Press Mentions
- IRX Therapeutics Presents Positive IRX-2 Phase 2a Head and Neck Squamous Cell Carcinoma Clinical Results at the European Society for Medical Oncology Annual Congress 2017September 11th, 2017
- Individualized Bioselection Treatment Methods Increase Survival Rates in Laryngeal CancerFebruary 13th, 2017
Grant Support
- Co-investigator (5%) - Develop a Therapeutic Nano-vaccine against Head and Neck Cancer.NIH2018–2023
- Co-Investigator (5%) - Statistical Methods for Cancer Biomarkers.NIH2017–2022
- Co-Investigator (5%) - Development of a Prognostic Compound Immunoscore for Head and Neck CancerNIH2018–2020
- Principal Investigator (50%) - Central Laboratory and Biorepository for INSPIRE: A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly DiagnoseBrooklyn Immunotherapeutics, Inc2015–2020
- The Molecular Basis Of Head And Neck Cancer Biology, Treatment And PreventionNational Cancer Institute2008–2011
- Role Of Soy Isoflavones, Smoking Abstinence And Molecular Markers In PreventionNational Cancer Institute2008–2011
- Developmental Research ProgramNational Cancer Institute2008–2011
- Career Development ProgramNational Cancer Institute2008–2011
- C1: AdministrationNational Cancer Institute2008–2011
- The Molecular Basis Of Head And Neck Cancer TherapyNational Cancer Institute2002–2007
- Advanced Research Training In OtolaryngologyNational Institute On Deafness And Other Communication Disorders2002–2006
- Research Training In The Communicative SciencesNational Institute On Deafness And Other Communication Disorders1995–2001
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: